David Altarac
doctorMale0.0Global Dominance: 0.00%
Dr. David Altarac serves as the chief medical officer at Innoviva Specialty Therapeutics, where he contributed to the development of zoliflodacin, a new antibiotic approved for treating gonorrhea, helping to address the growing issue of antibiotic resistance.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr. David Altarac, chief medical officer at Innoviva Specialty Therapeutics, discussed the potential of zoliflodacin to strengthen treatment options against gonorrhea.
FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistanceCNN·
United States· 2025-12-12
United States· 2025-12-12
